BeyondSpring (BYSI) Competitors $1.72 +0.00 (+0.05%) Closing price 05/21/2025 03:50 PM EasternExtended Trading$1.72 +0.00 (+0.06%) As of 05/21/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BYSI vs. ACB, IMMP, AURA, CGC, TSVT, ITOS, TERN, GLUE, LFCR, and RNACShould you be buying BeyondSpring stock or one of its competitors? The main competitors of BeyondSpring include Aurora Cannabis (ACB), Immutep (IMMP), Aura Biosciences (AURA), Canopy Growth (CGC), 2seventy bio (TSVT), iTeos Therapeutics (ITOS), Terns Pharmaceuticals (TERN), Monte Rosa Therapeutics (GLUE), Lifecore Biomedical (LFCR), and Cartesian Therapeutics (RNAC). These companies are all part of the "pharmaceutical products" industry. BeyondSpring vs. Aurora Cannabis Immutep Aura Biosciences Canopy Growth 2seventy bio iTeos Therapeutics Terns Pharmaceuticals Monte Rosa Therapeutics Lifecore Biomedical Cartesian Therapeutics Aurora Cannabis (NASDAQ:ACB) and BeyondSpring (NASDAQ:BYSI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, community ranking, dividends, analyst recommendations, institutional ownership and media sentiment. Which has stronger earnings and valuation, ACB or BYSI? BeyondSpring has lower revenue, but higher earnings than Aurora Cannabis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$320.81M0.91-$48.62M$0.05104.40BeyondSpring$1.88M37.05-$21.03MN/AN/A Does the MarketBeat Community prefer ACB or BYSI? Aurora Cannabis received 199 more outperform votes than BeyondSpring when rated by MarketBeat users. However, 66.79% of users gave BeyondSpring an outperform vote while only 59.63% of users gave Aurora Cannabis an outperform vote. CompanyUnderperformOutperformAurora CannabisOutperform Votes38459.63% Underperform Votes26040.37% BeyondSpringOutperform Votes18566.79% Underperform Votes9233.21% Do institutionals & insiders have more ownership in ACB or BYSI? 47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 40.3% of BeyondSpring shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Comparatively, 29.3% of BeyondSpring shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is ACB or BYSI more profitable? Aurora Cannabis has a net margin of 0.42% compared to BeyondSpring's net margin of 0.00%. Aurora Cannabis' return on equity of 0.59% beat BeyondSpring's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis0.42% 0.59% 0.42% BeyondSpring N/A N/A N/A Does the media favor ACB or BYSI? In the previous week, Aurora Cannabis and Aurora Cannabis both had 1 articles in the media. Aurora Cannabis' average media sentiment score of 0.81 beat BeyondSpring's score of 0.51 indicating that Aurora Cannabis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BeyondSpring 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend ACB or BYSI? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67BeyondSpring 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, ACB or BYSI? Aurora Cannabis has a beta of 1.94, indicating that its stock price is 94% more volatile than the S&P 500. Comparatively, BeyondSpring has a beta of 0.13, indicating that its stock price is 87% less volatile than the S&P 500. SummaryAurora Cannabis beats BeyondSpring on 11 of the 15 factors compared between the two stocks. Get BeyondSpring News Delivered to You Automatically Sign up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BYSI vs. The Competition Export to ExcelMetricBeyondSpringPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$69.51M$6.52B$5.37B$8.39BDividend YieldN/A2.65%5.22%4.10%P/E RatioN/A8.9226.7719.71Price / Sales37.05253.80393.17117.39Price / CashN/A65.8538.2534.62Price / Book-1.896.466.794.50Net Income-$21.03M$143.98M$3.23B$248.18M7 Day Performance2.62%2.03%1.53%0.20%1 Month Performance26.76%4.11%10.06%12.37%1 Year Performance-37.08%-2.87%16.74%7.04% BeyondSpring Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BYSIBeyondSpringN/A$1.72+0.0%N/A-33.4%$69.51M$1.88M0.0080Gap DownACBAurora Cannabis0.6189 of 5 stars$5.06+4.3%N/A-26.8%$272.64M$320.81M101.221,340IMMPImmutep1.4058 of 5 stars$1.87+1.1%$8.50+354.5%-39.9%$270.17M$5.14M0.002,021Gap DownAURAAura Biosciences2.4542 of 5 stars$5.35+2.3%$22.75+325.2%-14.2%$268.70MN/A-3.0950Earnings ReportInsider TradeGap UpCGCCanopy Growth1.4008 of 5 stars$1.46+11.5%$2.00+37.0%-82.2%$268.44M$276.75M-0.383,150Trending NewsTSVT2seventy bio1.5432 of 5 stars$5.00+0.2%$4.25-15.0%N/A$266.15M$37.86M-2.69440ITOSiTeos Therapeutics2.9745 of 5 stars$6.92+3.9%$25.50+268.5%-54.4%$264.86M$35M-2.2090Positive NewsAnalyst RevisionGap UpHigh Trading VolumeTERNTerns Pharmaceuticals4.0956 of 5 stars$3.02-0.7%$18.38+508.4%-51.1%$263.76MN/A-2.5640News CoveragePositive NewsGap DownGLUEMonte Rosa Therapeutics2.1802 of 5 stars$4.27+4.4%$15.50+263.0%-6.6%$262.65M$75.62M-2.3390Positive NewsLFCRLifecore Biomedical1.1426 of 5 stars$6.98+0.1%$8.00+14.6%+8.2%$258.43M$130.31M-12.46690Analyst ForecastRNACCartesian Therapeutics1.5334 of 5 stars$10.44+5.5%$42.50+307.1%-62.3%$256.78M$34.17M-0.2064News CoverageAnalyst Revision Related Companies and Tools Related Companies ACB Competitors IMMP Competitors AURA Competitors CGC Competitors TSVT Competitors ITOS Competitors TERN Competitors GLUE Competitors LFCR Competitors RNAC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BYSI) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeyondSpring Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BeyondSpring With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
